DiaMedica Therapeutics Inc.
Hedge Funds Holdings
Last updated:
DiaMedica Therapeutics Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 2.27% of the total amount of its stocks outstanding. This makes up a total of 472.00K shares of DiaMedica Therapeutics Inc.. Compared to the previous quarter, the number fell by -72.40% or -1.23M shares fewer. As for the holding position changes, 42.86% (6) of current hedge fund investors increased the number of shares held, 21.43% (3) of current holders sold a part of the shares held, and 7.14% (1) closed the holdings completely.
Hedge funds holding DiaMedica Therapeutics (Q4 2018 – Q1 2023)
| Q4 2018 | 7 |
|---|---|
| Q1 2019 | 10 |
| Q2 2019 | 15 |
| Q3 2019 | 14 |
| Q4 2019 | 12 |
| Q1 2020 | 18 |
| Q2 2020 | 20 |
| Q3 2020 | 30 |
| Q4 2020 | 33 |
| Q1 2021 | 38 |
| Q2 2021 | 38 |
| Q3 2021 | 30 |
| Q4 2021 | 34 |
| Q1 2022 | 26 |
| Q2 2022 | 22 |
| Q3 2022 | 22 |
| Q4 2022 | 25 |
| Q1 2023 | 14 |
Hedge funds changes in DiaMedica Therapeutics positions (Q4 2018 – Q1 2023)
| Q4 2018 | 7 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2019 | 6 | 1 | 2 | 3 | -2 |
| Q2 2019 | 7 | 3 | 2 | 2 | 1 |
| Q3 2019 | 3 | 5 | 4 | 4 | -2 |
| Q4 2019 | 2 | 4 | 2 | 4 | 0 |
| Q1 2020 | 7 | 6 | 2 | 1 | 2 |
| Q2 2020 | 6 | 3 | 4 | 4 | 3 |
| Q3 2020 | 13 | 11 | 2 | 3 | 1 |
| Q4 2020 | 11 | 10 | 5 | 8 | -1 |
| Q1 2021 | 10 | 15 | 8 | 5 | 0 |
| Q2 2021 | 8 | 14 | 8 | 8 | 0 |
| Q3 2021 | 4 | 12 | 10 | 12 | -8 |
| Q4 2021 | 6 | 12 | 7 | 2 | 7 |
| Q1 2022 | 1 | 7 | 11 | 8 | -1 |
| Q2 2022 | 1 | 6 | 6 | 5 | 4 |
| Q3 2022 | 5 | 5 | 6 | 5 | 1 |
| Q4 2022 | 6 | 8 | 5 | 3 | 3 |
| Q1 2023 | 0 | 6 | 3 | 1 | 4 |
Hedge funds changes in DiaMedica Therapeutics stock options (Q4 2018 – Q1 2023)
| Q4 2018 | 0 | 0 |
|---|---|---|
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 63,000 | 534,000 |
| Q3 2021 | 172,000 | 465,000 |
| Q4 2021 | 138,000 | 302,000 |
| Q1 2022 | 157,000 | 87,000 |
| Q2 2022 | 175,000 | 57,000 |
| Q3 2022 | 10,000 | 11,000 |
| Q4 2022 | 2,528 | 11,158 |
| Q1 2023 | 10,863,000 | 0 |